Fabian Tenenbaum
2019
In 2019, Fabian Tenenbaum earned a total compensation of $1.4M as Chief Executive Officer at Bellerophon Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Bonus | $372,000 |
|---|---|
| Option Awards | $585,704 |
| Salary | $425,492 |
| Other | $16,800 |
| Total | $1,399,996 |
Tenenbaum received $585.7K in option awards, accounting for 42% of the total pay in 2019.
Tenenbaum also received $372K in bonus, $425.5K in salary and $16.8K in other compensation.
Rankings
In 2019, Fabian Tenenbaum's compensation ranked 7,671st out of 13,971 executives tracked by ExecPay. In other words, Tenenbaum earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,671 out of 13,971 | 45th |
Division Manufacturing | 2,991 out of 5,701 | 48th |
Major group Chemicals And Allied Products | 1,123 out of 2,200 | 49th |
Industry group Drugs | 957 out of 1,886 | 49th |
Industry Pharmaceutical Preparations | 710 out of 1,398 | 49th |
Source: SEC filing on April 23, 2020.
Tenenbaum's colleagues
We found two more compensation records of executives who worked with Fabian Tenenbaum at Bellerophon Therapeutics in 2019.